Company | Invesco Ltd. | Ticker | IVZ (NYSE) |
Upcoming Earnings Date | July 28, 2026 (Before Market Open) | Preparation Date | July 27, 2026 |
Last Reported Period | Q1 2026 (April 28, 2026) | Reporting Period | Q2 2026 (June 30, 2026) |
Key Takeaway: Setup leans toward a beat — AUM surged ~14% quarter-over-quarter to $2.47T driven by QQQ inflows and market appreciation, creating a high-revenue-growth quarter that consensus may be underestimating; the biggest swing factor is whether operating margin can hold or expand despite QQQ mix pressure on net revenue yield.
Heading into Q2 2026 results, the setup for IVZ is constructively bullish. The bar is achievable: consensus EPS of $0.66 implies 86% year-over-year growth, but the real story is that preliminary AUM of $2.47T at June 30 — up 14.4% from Q1-end — was driven by a $120B surge in QQQ AUM in the first two months of Q2 alone (management disclosed at the Morgan Stanley Financials Conference), creating what the CFO described as "massive revenue growth" for the quarter. Management's tone has been consistently confident since the Q1 print, with the CEO and CFO both reiterating the path to high-30s operating margin at two investor conferences, and monthly flow data showing $18B in April, $19B in May, and $8B in June of net long-term inflows — well above the $27B consensus estimate for the full quarter. Estimate revisions have moved meaningfully higher since Q1 earnings (EPS consensus up ~10% from $0.61 to $0.66; revenue up ~5% from $1.27B to $1.33B), suggesting the Street has already partially priced in the AUM tailwind, though the magnitude of QQQ-driven revenue growth may still surprise. The stock has already rallied ~16% since the Q1 print, outperforming both the S&P 500 (+4%) and the insurance/financial ETF KIE (+12%), so some beat is priced in. The key wildcard is net revenue yield: QQQ's ~6 bps fee rate is dilutive to the blended yield, and if the mix shift is more severe than modeled, operating margin could disappoint even on strong revenue — that is the single number to watch on the print.
Key Takeaway: Consensus is a moderate bar on EPS and revenue given the AUM tailwind, but net long-term flows are the bigger swing factor — the Street's $44.9B estimate looks high relative to the $45B of inflows implied by monthly data ($18B + $19B + $8B = $45B), suggesting flows may roughly meet consensus while revenue surprises to the upside on QQQ AUM growth.
KPI | Q1 2026 Actual | Q2 2025 Actual | Q2 2026 Consensus Est. | YoY Change | Guidance | Cons. vs. Guidance |
Adj. EPS (Diluted - Operating) | $0.57 | $0.36 | $0.66 | +86.1% YoY | No specific EPS guidance | N/A |
Net Revenues - Operating | $1,264M | $1,105M | $1,333M | +20.6% YoY | Opex ~$3.275B FY (flat mkt) | N/A (revenue not guided) |
Operating Income - Operating | $436M | $344M | $488M | +41.9% YoY | No specific guidance | N/A |
Long-Term Net Flows | $21.8B | $15.6B | $44.9B | +188% YoY | No specific guidance | N/A |
Ending AUM | $2,159.5B | $2,001.4B | $2,473.2B | +23.6% YoY | ~$2.3T (flat mkt assumption) | +7.5% above guidance base |
Net Revenue Yield - Operating | 22.8 bps (exit rate) | 23.3 bps | 22.6 bps | -30 bps YoY | Stabilization ~22-23 bps | Within guidance range |
Total Opex - Operating | $828M | $760M | $845M | +11.2% YoY | ~$3.275B FY 2026 | ~$818M Q2 implied; cons. +3.3% above |
Sources: Visible Alpha consensus and actuals data. Ending AUM and monthly flow data from Invesco 8-K AUM releases (April and June 2026). Net revenue yield exit rate from Q1 2026 earnings call. Consensus EPS of $0.66 per Zacks/internet sources; VA consensus shows $0.664.
Top 2 KPIs: Adjusted EPS (Diluted - Operating) and Long-Term Net Flows
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Adj. EPS | $0.57 | $0.575 | -0.9% | Miss |
Q1 2026 | LT Net Flows | $21.8B | $22.0B | -1.0% | In-Line |
Q4 2025 | Adj. EPS | $0.62 | $0.583 | +6.3% | Beat |
Q4 2025 | LT Net Flows | $19.1B | $18.9B | +1.1% | Beat |
Q3 2025 | Adj. EPS | $0.61 | $0.436 | +39.9% | Beat |
Q3 2025 | LT Net Flows | $28.9B | $27.4B | +5.5% | Beat |
Q2 2025 | Adj. EPS | $0.36 | $0.408 | -11.8% | Miss |
Q2 2025 | LT Net Flows | $15.6B | $13.9B | +12.2% | Beat |
Pattern: IVZ has beaten on LT Net Flows in 3 of the last 4 quarters, demonstrating consistent organic growth momentum. EPS has been more mixed — a large beat in Q3 2025 (partly driven by QQQ reclassification timing), a solid beat in Q4 2025, but a slight miss in Q1 2026 and Q2 2025, suggesting the Street has learned to set a tighter EPS bar. Flows are the more reliable beat driver.
Source: Visible Alpha consensus and actuals data.
Key Takeaway: Management's tone has been consistently confident since the Q1 print, with no formal guidance revisions but meaningful positive data points disclosed at two investor conferences (Bernstein in May, Morgan Stanley in June) that effectively raised the bar on AUM and flows.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 28) | Revised Guidance | Current Consensus | Note |
FY 2026 Operating Expenses | ~$3.275B (flat markets from ~$2.3T AUM) | $3.378B | Unchanged; AUM now ~$2.47T, above guidance base — variable comp will be higher | |
Q2 2026 Non-GAAP Tax Rate | 25%–26% (excl. discrete items) | N/A (not tracked separately) | Unchanged; consistent with prior quarters | |
Operating Margin Path | Mid-30s near-term; high-30s long-term | ~36.6% Q2 implied (Op. Inc. / Rev.) | Reiterated at Morgan Stanley Conference (Jun 10); Q1 was seasonally low at 34.5% | |
QQQ Marketing Budget | $60M–$100M (fully discretionary, in run rate) | N/A | Reiterated at Bernstein Conference (May 27); management has full discretion to deploy | |
Canada Partnership (CI Financial) | Close end of Q2 2026; ~$19B AUM transition; -$5M to -$10M/qtr OI impact in Q3/Q4 | N/A | Expected to close as guided; modest Q3/Q4 headwind now in estimates | |
Hybrid Platform (Alpha NextGen) Costs | $10M–$15M/qtr implementation; complete by year-end 2026; ≥$60M savings in 2027 | N/A | On track; reiterated at Bernstein (May 27); incremental AUM-on-platform costs building to ~$10M/qtr | |
Capital Return (Buyback) | $40M/qtr buyback; ~60% total payout ratio target for 2026 | N/A | Unchanged; $1B buyback authorization in place; revolver paydown remains priority | |
AUM Flows (Intra-Quarter Disclosure) | April: ~$17–18B LT inflows; QQQ turned positive | May: ~$19B (Bernstein, May 27); June: $8.0B (8-K, Jul 10) | $44.9B Q2 consensus | ↑ Positive intra-quarter disclosures at conferences; monthly 8-K confirmed strong Q2 total |
Key Takeaway: Estimates have moved meaningfully higher since the Q1 2026 print — Q2 EPS consensus is up ~10% and revenue up ~5% from the post-earnings baseline — reflecting the AUM and QQQ tailwind. The gap between current consensus and the initial guidance base suggests the Street has already partially priced in the upside, but the magnitude of QQQ-driven revenue growth may still leave room for a positive surprise.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (May 5, 2026) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Cons. vs. Guidance (%) |
Adj. EPS (Q2 2026) | $0.605 | $0.664 | +9.7% | No specific guidance | No specific guidance | N/A | N/A |
Net Revenues - Operating (Q2 2026) | $1,269M | $1,333M | +5.0% | No specific guidance | No specific guidance | N/A | N/A |
LT Net Flows (Q2 2026) | $27.0B | $44.9B | +66.3% | No specific guidance | No specific guidance | N/A | N/A |
Adj. EPS (FY 2026) | $2.567 | $2.852 | +11.1% | No specific guidance | No specific guidance | N/A | N/A |
Net Revenues - Operating (FY 2026) | $5,179M | $5,441M | +5.1% | Opex ~$3.275B | Unchanged | Flat | N/A (revenue not guided) |
Total Opex - Operating (FY 2026) | $3,295M | $3,378M | +2.5% | ~$3,275M | ~$3,275M (unchanged) | Flat | +3.1% above guidance |
The large upward revision in Q2 LT Net Flows consensus (+66% from the post-earnings baseline) reflects intra-quarter disclosures at investor conferences and the monthly AUM 8-K releases. The FY 2026 opex consensus running ~3% above guidance midpoint reflects the variable compensation component tied to higher AUM and revenues — this is expected and not a concern, as the revenue upside more than offsets it.
Source: Visible Alpha consensus and actuals data (as-of date: May 5, 2026 for baseline; latest for current). Guidance from Q1 2026 earnings call (April 28, 2026).
Key Takeaway: IVZ has rallied ~16% since Q1 earnings (vs. S&P 500 +4%, KIE +12%), driven by a combination of strong AUM inflow disclosures at investor conferences and upward estimate revisions — the outperformance is fundamentally supported, though the stock's run means a beat is partially priced in heading into the print.
IVZ vs. KIE (Insurance ETF) vs. S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings (April 28, 2026). IVZ: +16.4% | KIE: +11.5% | SPY: +3.8%
Sector ETF used: KIE (SPDR S&P Insurance ETF) — selected as the closest available financial sector ETF proxy for asset managers/diversified financials. Note: a dedicated asset manager ETF (e.g., IAI) would be more precise but KIE captures the broader financial services sentiment.
Key events driving performance since April 28, 2026:
Key Takeaway: The most important development since Q1 earnings is the QQQ AUM surge of ~$120B in the first two months of Q2, driven by AI-trade demand and anticipated IPO activity — this is the single biggest driver of Q2 revenue upside and the primary reason estimates have moved higher.
Key Takeaway: No open-market buys or discretionary sells by named executives — all insider activity consists of routine tax withholding (code F) and RSU vesting (code M) transactions, plus standard annual director equity grants. No unusual signals.
Name | Title | Transaction Type | Shares / Value | Date | Note |
Andrew Schlossberg | President & CEO | Tax Withholding (F) | 156,007 shares | Jul 2, 2026 | Shares withheld for tax on RSU vesting; not a discretionary sale |
Laura Allison Dukes | Chief Financial Officer | Tax Withholding (F) | 52,003 shares | Jul 2, 2026 | Shares withheld for tax on RSU vesting; not a discretionary sale |
Jeffrey H. Kupor | Senior Managing Director | Tax Withholding (F) | 26,002 shares | Jul 2, 2026 | Shares withheld for tax on RSU vesting; not a discretionary sale |
Andrew Tak Shing Lo | Senior Managing Director | RSU Vesting (M) / Delivery (D) | 116,754 shares vested | Jul 2, 2026 | RSU conversion to common shares; routine vesting event |
Multiple Directors (9 individuals) | Board Directors | Annual Equity Grant (A) | 8,112 shares each | May 15, 2026 | Standard annual director compensation grant; routine |
Invesco Advisers, Inc. | 10% Owner / Director (fund entity) | Various (A/D) | Multiple transactions in fund share classes | Apr–Jul 2026 | Routine fund subscription/redemption activity in Invesco-managed funds; not economically meaningful for IVZ stock |
No open-market purchases (code P) or discretionary open-market sales (code S) were filed by any named executive or director during the April 28 – July 27, 2026 window. All transactions are obligation-driven (tax withholding on vesting) or routine compensation grants. The absence of discretionary insider selling ahead of earnings is a mild positive signal.
Source: SEC Form 4 filings via insider transaction dataset.
Key Takeaway: Both BlackRock (BLK, reported July 15) and Cohen & Steers (CNS, reported July 17) reported strong Q2 2026 results with record or near-record inflows, margin expansion, and positive market commentary — all of which are constructive read-throughs for IVZ's Q2 print. The industry backdrop is clearly favorable.
Note: Only peer commentary from Q2 2026 earnings calls (reporting on the current quarter) is included below. Q1 2026 earnings commentary from peers has been excluded as it pertains to a prior period.
Read-Through Signal: Strongly Positive
Read-Through Signal: Positive (Real Assets / REIT-Focused)
Theme | BLK Signal | CNS Signal | IVZ Implication |
Industry Flows | Record inflows; 2x prior year | Strongest in 4.5 years | Positive — confirms IVZ's strong Q2 flow narrative |
ETF Demand | $178B iShares inflows; active ETF momentum | Active ETFs >$1B; all strategies moving to ETF | Positive — IVZ's $1.2T ETF platform benefits |
Operating Margin | 45.9% (+260 bps YoY); not a ceiling | 36.3%; expense growth below revenue | Positive — validates IVZ's high-30s margin path |
Market Environment | "Very optimistic"; US equities at new highs | Resilient economy; real assets outperforming | Positive — supports AUM appreciation and fee revenue |
International / Asia | Europe $80B YTD; Asia Pacific $100B+ in quarter | Global pipeline in 11 countries | Positive — validates IVZ's Asia/Europe growth narrative |
Private Markets / Wealth | $15B private markets inflows in Q2 | Private RE fundraising in wealth down ~5% | Mixed — institutional strong; wealth channel still slow |
QQQ Competition | BLK confirmed Nasdaq 100 ETF filing; no launch timeline | N/A | Neutral/Watch — threat confirmed but not imminent |